PropertyValue
?:abstract
  • There are a few aspects that we would like to add to complement the discussion in EL-Arabey and Abdalla [1]. Firstly, the authors suggested that the reduction of weight with the use of metformin, especially among obese patients, may have a protective effect on mortality from COVID-19. This article is protected by copyright. All rights reserved.
?:creator
?:doi
  • 10.1002/jmv.26090
?:doi
?:journal
  • J_Med_Virol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/982b3d4fb7f6059976c59b11ef4b52c81c91c078.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7283671.xml.json
?:pmcid
?:pmid
?:pmid
  • 32470199.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Metformin use amid coronavirus disease 2019 pandemic
?:type
?:year
  • 2020-06-09

Metadata

Anon_0  
expand all